1. RETRACTED: STAT3 Promotes Invasion and Aerobic Glycolysis of Human Oral Squamous Cell Carcinoma via Inhibiting FoxO1
   Min Zheng et al, 2019, Frontiers in Oncology CrossRef
2. Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers
   Yanhong Ni et al, 2022, Frontiers in Immunology CrossRef
3. Immunohistochemical assessment of growth factor signaling molecules: MAPK, Akt, and STAT3 pathways in oral epithelial precursor lesions and squamous cell carcinoma
   Kazuki Tashiro et al, 2020, Odontology CrossRef
4. Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment
   Bedanta Bhattacharjee et al, 2023, Frontiers in Pharmacology CrossRef
5. Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma
   Qiang Li et al, 2020, Frontiers in Oncology CrossRef
6. The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer
   Elina Khatoon et al, 2022, Archives of Pharmacal Research CrossRef
7. RETRACTED: MicroRNA-200a Inhibits Inflammation and Atherosclerotic Lesion Formation by Disrupting EZH2-Mediated Methylation of STAT3
   Jinpeng Wang et al, 2020, Frontiers in Immunology CrossRef
8. STAT3 Mediated miR-30a-5p Inhibition Enhances Proliferation and Inhibits Apoptosis in Colorectal Cancer Cells
   Chun-Chia Cheng et al, 2020, International Journal of Molecular Sciences CrossRef
9. Palmitic Acid-Induced miR-429-3p Impairs Myoblast Differentiation by Downregulating CFL2
   Mai Thi Nguyen et al, 2021, International Journal of Molecular Sciences CrossRef
10. STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma
    Mingjing Jiang et al, 2022, Cells CrossRef
11. The Impact of STAT3 rs1053005 Variation on Type 1 Diabetes Mellitus Susceptibility: Association Study and in Silico Analysis
    Maryam Zandi et al, 2022, Immunological Investigations CrossRef
12. Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma
    Yuxi Cheng et al, 2024, Clinical Epigenetics CrossRef